ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

Budget Resolution Includes Extra Money For NCI

July 2, 1982

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995

Dial Access Offers Caner Consultation Services

February 21, 1975

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005